Endophthalmitis outbreak associated with repackaged bevacizumab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2015-01, Vol.21 (1), p.171-173
Hauptverfasser:	Edison, Laura S, Dishman, Hope O, Tobin-D'Angelo, Melissa J, Allen, C Richard, Guh, Alice Y, Drenzek, Cherie L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Carnobacteriaceae - isolation & purification Complications and side effects Contamination Development and progression Disease Outbreaks Distribution drug compounding Drug Contamination Endophthalmitis Endophthalmitis - epidemiology Endophthalmitis - microbiology Endophthalmitis Outbreak Associated with Repackaged Bevacizumab eye infections Female Georgia - epidemiology Gram-positive bacterial infections Gram-Positive Bacterial Infections - epidemiology Gram-Positive Bacterial Infections - microbiology Gram-Positive Bacterial Infections - transmission Humans Indiana - epidemiology Letter Letters to the Editor Macular Degeneration - drug therapy Male Middle Aged Off-Label Use Vitreous Body - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!